Silent Inflammation The Hidden Driver of Multisystem Chronic Disease Abstract Chronic low grade inflammation, often referred to as silent inflammation, is increasingly recognized as a persistent inflammatory state that occurs in the absence of the classical signs and symptoms associated with acute inflammation.
Author: Nancy Ogbonna
Rare Disease Diagnosis: The Promise of Whole-Genome Sequencing in Pediatrics
Rare Disease Diagnosis The Promise of Whole-Genome Sequencing in Pediatrics Abstract Rare diseases collectively affect millions of children worldwide and represent a significant source of morbidity, mortality, and long term disability. Although individual rare disorders have low prevalence, their cumulative impact places a substantial
Precision Endocrinology: How Genomic Testing Improves Thyroid Treatment Outcomes
Precision Endocrinology How Genomic Testing Improves Thyroid Treatment Outcomes Introduction Precision endocrinology represents a paradigm shift in the management of thyroid disorders, grounded in an expanding body of genetic and molecular evidence. Large scale genetic studies have demonstrated that approximately 57 to 71 percent
New Frontiers in Male Hypogonadism: Are We Over-Treating Low Testosterone?
New Frontiers in Male Hypogonadism Are We Over-Treating Low Testosterone Abstract Male hypogonadism has emerged as one of the most intensively debated topics in men’s health over the past two decades. Advances in laboratory testing, increased awareness of androgen deficiency, and widespread direct to consumer marketing have
Is Type 2 Diabetes Reversible? New Research Challenges Medical Consensus
Is Type 2 Diabetes Reversible? New Research Challenges Medical Consensus Introduction The concept of type 2 diabetes reversibility represents a profound shift in the understanding and management of a condition long regarded as chronic and progressive. Diabetes remains a major global health burden, with prevalence
Long COVID and the Brain: Decoding Post-Viral Neuroinflammation
Long COVID and the Brain: Decoding Post-Viral Neuroinflammation Abstract Long COVID has emerged as a significant and evolving global health challenge, affecting millions of individuals following acute infection with SARS-CoV-2. While respiratory and systemic symptoms were initially the primary focus of clinical attention, it has
The Internist’s Role in the Longevity Movement: Separating Science from Pseudoscience
The Internist’s Role in the Longevity Movement Separating Science from Pseudoscience Abstract The longevity movement has gained considerable traction in recent years, driven by advances in molecular biology, increased public interest in healthy aging, and widespread media coverage of anti-aging interventions. Promises of extended lifespan
The Role of the Gut Microbiome in Neurological Disorders
The Role of the Gut Microbiome in Neurological Disorders Abstract The gut microbiome has emerged as a central component in the evolving understanding of neurological health and disease. Advances in molecular biology, metagenomics, and neuroimmunology have revealed that the intestinal microbial ecosystem plays a significant role
The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy?
The Tirzepatide Revolution: Is Dual Agonism the End of Single-Pathway Therapy? Abstract The development of tirzepatide, a first in class dual glucose dependent insulinotropic polypeptide and glucagon like peptide 1 receptor agonist, represents a potentially transformative advance in the management of type 2 diabetes and obesity. By simultaneously targeting
Why Tau Antibody Trials Failed in Alzheimer’s: New Evidence Reveals Critical Gaps
Why Tau Antibody Trials Failed in Alzheimer’s New Evidence Reveals Critical Gaps Introduction Tau directed antibody therapies represent one of the most scientifically compelling yet clinically challenging areas in the treatment of Alzheimer’s disease. Alzheimer’s disease is a progressive neurodegenerative disorder whose prevalence doubles approximately
